Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Universitair Ziekenhuis Leuven
InstitutionResearch output, impact & collaborations
Universitair Ziekenhuis Leuven is a research organisation in Leuven, BE. OpenAlex records 18,212 works and 1,597,361 citations for it. 2,572 researchers list it as their most recent affiliation.
18,212
Works
1,597,361
Citations
2,572
Researchers
80.4
Avg h-index
How has Universitair Ziekenhuis Leuven's publication output changed over time?
ScholarIQpublication output · 2005–2020
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2020.
1
1
1
2
1
1
3
1
1
200520062010201120122014201720182020
Who are the most-cited researchers behind Universitair Ziekenhuis Leuven?
ScholarIQtop researchers by citations
What are the most-cited papers on Universitair Ziekenhuis Leuven?
ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
Annals of the Rheumatic Diseases. 20175,784 CitationsOPEN ACCESS
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Kevin C. Oeffinger, Ann Mertens, Charles A. Sklar, Toana Kawashima, Melissa M. Hudson, Anna T. Meadows, Debra L. Friedman, Neyssa Marina, Wendy L. Hobbie, Nina S. Kadan‐Lottick, Cindy L. Schwartz, Wendy M. Leisenring, Leslie L. Robison
New England Journal of Medicine. 20063,617 Citations
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg, Jack Satsangi, Tariq Ahmad, Ian Arnott, Çharles N. Bernstein, Steven R. Brant, R. Caprilli, Jean–Frédéric Colombel, Christoph Gasché, Karel Geboes, Derek P. Jewell, Amir Karban, Edward V. Loftus, A. S. Peña, Robert H. Riddell, David B. Sachar, Stefan Schreiber, A. Hillary Steinhart, Stephan R. Targan, Séverine Vermeire, Bryan F. Warren
S4210173357. 20053,407 CitationsOPEN ACCESS
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning
New England Journal of Medicine. 20173,241 CitationsOPEN ACCESS
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito, C. Lombard Bohas, Edward M. Wolin, Eric Van Cutsem, Timothy J. Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G.E. de Vries, Paola Tomassetti, Marianne Pavel, Sakina Hoosen, T Haas, Jeremie Lincy, David Lebwohl, Kjell Öberg
New England Journal of Medicine. 20112,863 CitationsOPEN ACCESS
How much of the research on Universitair Ziekenhuis Leuven is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
8%
Green
17%
Hybrid
8%
Bronze
33%
Closed
33%